Novartis: Sandoz launches version of popular EpiPen

(CercleFinance.com) - Sandoz, Novartis' generics unit, is launching an injector for the emergency treatment of allergic reactions on the US market, the company said on Wednesday.


Sandoz said it is launching this medicine as an affordable, single-dose, pre-filled syringe, as an alternative to the popular EpiPen auto-injectors.

The injector is indicated for the emergency treatment of allergic reactions such as anaphylaxis to stinging and biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances and other allergens.



Copyright (c) 2019 CercleFinance.com. All rights reserved.